Home/Pipeline/Oticon Own SI™

Oticon Own SI™

Hearing Loss

CommercialActive

Key Facts

Indication
Hearing Loss
Phase
Commercial
Status
Active
Company

About Oticon

Oticon, a cornerstone of the Danish Demant Group, is a mission-driven medical device company with a 120-year legacy of innovating in hearing care. Its core strategy is built on the BrainHearing™ paradigm, which focuses on supporting the brain's natural listening processes rather than merely amplifying sound, a differentiator supported by its own independent research facility. The company achieves global scale through a vast, professional-led distribution network across 130 countries, commercializing a mature portfolio of AI-enabled hearing aids and accessories designed to mitigate the broader health risks associated with hearing loss.

View full company profile

Other Hearing Loss Drugs

DrugCompanyPhase
ADB-105Adolore BioTherapeuticsPre-clinical
Next-Generation Connectivity & Digital Health FeaturesAdvanced BionicsDevelopment
Next-Gen AI Hearing AidsStarkeyDevelopment/Commercialization
Oticon Zeal™OticonCommercial Launch
Oticon Intent™OticonCommercial
Oticon Jet PXOticonCommercial